How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
TransOral Robotic Surgery Market
- By Surgery Type: Transoral Robotic Surgery for Oropharyngeal Cancer, Transoral Robotic Surgery for Laryngeal Cancer, Transoral Robotic Surgery for Hypopharyngeal Cancer, Transoral Robotic Surgery for Sleep Apnea, Transoral Robotic Surgery for Thyroidectomy
- By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics
- By Component: Robotic Surgical Systems, Instruments and Accessories, Imaging Systems, Software and Services
- By Application: Oncological Procedures, Non-Oncological Procedures
Top segment
Transoral Robotic Surgery for Oropharyngeal Cancer XX% share · $X,XXXM
In the full report →
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Transoral Robotic Surgery for Oropharyngeal Cancer leads By Surgery Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 13 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 263 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.160 →
- 11 Company Profiles 13 players: SWOT & benchmarking p.168 →
Full report · locked preview
Everything inside the TransOral Robotic Surgery Market report
A complete, evidence-based study - 11 chapters and 110 sections covering market size, segmentation across 4 axes, regional analysis and 13 company profiles, forecast to 2033.
Segmentation covered
Surgery Type 5
End-User 3
Component 4
Application 2
Companies profiled
Intuitive Surgical Inc.
Medrobotics Corporation
Stryker Corporation
TransEnterix
Inc. (Asensus Surgical)
Smith & Nephew plc
Verb Surgical (a collaboration between Verily and Johnson & Johnson)
CMR Surgical Ltd
Titan Medical Inc.
Renishaw plc
Avatera Medical GmbH
Memic Innovative Surgery Ltd.
+1 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
13 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Intuitive Surgical Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Medrobotics Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Stryker Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →TransEnterix
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Inc. (Asensus Surgical)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Smith & Nephew plc
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →Verb Surgical (a collaboration between Verily and Johnson & Johnson)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →CMR Surgical Ltd
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Titan Medical Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Renishaw plc
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Avatera Medical GmbH
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.214 →Memic Innovative Surgery Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Medtronic plc
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$4,519M by 2033 · 8.6% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Transoral Robotic Surgery for Oropharyngeal Cancer40.9
- Transoral Robotic Surgery for Laryngeal Cancer18.6
- Transoral Robotic Surgery for Hypopharyngeal Cancer14.5
- Transoral Robotic Surgery for Sleep Apnea17.4
- Transoral Robotic Surgery for Thyroidectomy8.6
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$768.7M → $1,543M · 9.1%
Europe$535.8M → $974.8M · 7.8%
Asia Pacific$489.2M → $959.6M · 8.8%
Latin America$302.8M → $610.9M · 9.2%
Middle East and Africa$232.9M → $411.7M · 7.4%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →8.602026
8.592027
8.622028
8.632029
8.632030
8.642031
8.662032
8.682033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Intuitive Surgical Inc.20.0
- Medrobotics Corporation12.2
- Stryker Corporation7.6
- TransEnterix10.7
- Inc. (Asensus Surgical)15.9
- Smith & Nephew plc5.6
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Surgery Type24.5%
End-User27.7%
Component12.2%
Application35.6%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.3
- Europe21.7
- Asia Pacific21.3
- Latin America13.6
- Middle East and Africa9.1
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Intuitive Surgical Inc. | 97 | 83 | 85 | 97 | 93 | 84 | 90 |
| Medrobotics Corporation | 88 | 70 | 79 | 91 | 91 | 90 | 85 |
| Stryker Corporation | 86 | 79 | 67 | 73 | 87 | 64 | 76 |
| TransEnterix | 78 | 59 | 59 | 67 | 79 | 74 | 69 |
| Inc. (Asensus Surgical) | 68 | 67 | 53 | 55 | 63 | 71 | 63 |
| Smith & Nephew plc | 54 | 66 | 71 | 56 | 48 | 60 | 59 |
| Verb Surgical (a collaboration between Verily and Johnson & Johnson) | 44 | 55 | 56 | 46 | 46 | 43 | 48 |
| CMR Surgical Ltd | 42 | 39 | 51 | 59 | 41 | 40 | 45 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Intuitive Surgical Inc.
- Medrobotics Corporation
- Stryker Corporation
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc. | ✓ | ✓ | ◐ | ✓ | ✓ | ✓ |
| Medrobotics Corporation | ✓ | ✓ | ✓ | ◐ | ✓ | ◐ |
| Stryker Corporation | ✓ | ✓ | ✓ | ✓ | ◐ | ◐ |
| TransEnterix | ◐ | − | ◐ | ◐ | ◐ | ◐ |
| Inc. (Asensus Surgical) | ✓ | ◐ | − | ◐ | ◐ | ◐ |
| Smith & Nephew plc | ◐ | ✓ | ◐ | − | − | ◐ |
| Verb Surgical (a collaboration between Verily and Johnson & Johnson) | − | ◐ | ◐ | − | − | − |
| CMR Surgical Ltd | − | − | − | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Intuitive Surgical Inc.90
2Medrobotics Corporation85
3Stryker Corporation76
4TransEnterix69
5Inc. (Asensus Surgical)63
6Smith & Nephew plc59
7Verb Surgical (a collaboration between Verily and Johnson & Johnson)48
8CMR Surgical Ltd45
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Intuitive Surgical Inc.Medrobotics Corporation
Challenger2
Strong scale, closing on the leaders.
Stryker CorporationTransEnterix
Contender2
Focused players with pockets of strength.
Inc. (Asensus Surgical)Smith & Nephew plc
Niche2
Specialists in a single segment or region.
Verb Surgical (a collaboration between Verily and Johnson & Johnson)CMR Surgical Ltd
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Surgery Type in North America, then scale across TransOral Robotic Surgery Market — a $349M beachhead inside a $6.19B market.
Beachhead (SOM)$349Mobtainable near-term
Serviceable (SAM)$2.33Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Transoral Robotic Surgery for Oropharyngeal Cancer
Best fit — highest urgency & budget in Surgery Type.
Economic buyer79 fit
Transoral Robotic Surgery for Laryngeal Cancer
Strong fit — clear ROI and a fast path to value.
End user67 fit
Transoral Robotic Surgery for Hypopharyngeal Cancer
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Surgery Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add End-User & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Component
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel31%
Digital / self-serve19%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Surgery Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win TransOral Robotic Surgery Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified22%
Evaluation13%
Closed-won8%
$13.2KCAC
$65KLTV
4.9:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
TransOral Robotic Surgery Market is a resilient opportunity — $7.60B by 2033, compounding at 4.8%.
TAM · 2025$5.22Btoday
TAM · 2033$7.60Bforecast
CAGR4.8%2027–2033
Cumulative$57.1Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$7.60BTotal addressable market
SAM$2.87BServiceable available market
SOM$480MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.8% CAGR
Demand compounds through 2033, outpacing GDP across Surgery Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Surgery Type moving from early to mainstream — durable secular demand.
Consolidation upside
13+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$7.60BLarge & growingTAM by 2033 at 4.8% CAGR
$2.87BServiceable nowreachable with today’s model
$480MBeachhead winobtainable near-term share
13+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.92BBear3.1% CAGR
$7.60BBase4.8% CAGR
$9.72BBull6.4% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & End-User optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
TransOral Robotic Surgery Market — a $7.25B market by 2033. Plan: grow share from 11.6% to 18.7%.
Market size · 2033$7.25Btotal addressable
Market CAGR8.5%2027–2033
Target share18.7%from 11.6% today
Revenue ambition$1.36Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 11.6% | 18.7% | At risk |
| Revenue | $845M | $1.36B | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | On track |
| Gross margin | 29.4% | 43.5% | On track |
| Customer retention | 89.8% | 95.2% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Surgery Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build End-User capability
A defensible second engine — invest in End-User to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Surgery Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch End-User
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $175M capacity & capability investment
- Greenlight bolt-on M&A in End-User
- Authorise North America expansion plan
- Fund R&D program for Surgery Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossOn track
- Input-cost & supply riskBehind
- Regulatory / policy changeAhead
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the TransOral Robotic Surgery Market conversation — a $3.60B market you can size, segment and defend in minutes.
Market size · 2033$3.60Btotal opportunity
Growth10.9%CAGR to 2033
Addressable buyers1,280+accounts in scope
Typical ROI4.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Surgery Type
Goal Grow share in Surgery Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.5×return on cost, year one
< 3 mopayback period
$63K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
13+players profiled in this market
Coverage includes
Intuitive Surgical Inc.Medrobotics CorporationStryker CorporationTransEnterixInc. (Asensus Surgical)Smith & Nephew plcVerb Surgical (a collaboration between Verily and Johnson & Johnson)CMR Surgical Ltd+5 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your TransOral Robotic Surgery Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
TransOral Robotic Surgery Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Transmission Electron Cryomicroscopy (CryoTEM) Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportTransmission Densitometers Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportTransmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportTransmembrane Protein Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportTrans-Jejunal Feeding Tube Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportTransitional Care Management (TCM) Services Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportTransitional Care Management Services Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportTransillumination Vein Finder Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportTransient Protein Expression Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportTransient Absorption Spectrometer (TAS) Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportTransglutaminase IgA ELISA Test Kit Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportTransglutaminase Enzyme Market
Market size, share, segmentation and regional forecast.
$765M market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.